Delivery Order SPE2DB22D2006-SPE2DB25FV5VM

Award Date 10/23/24
Potential Completion Date 10/24/24
Potential Value $53K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,879.58 firm fixed-price delivery order is for Nurtec ODT 75 mg tablets, with a period of performance through February 26, 2024. The contract is not designated with a set-aside requirement. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,207.82 firm-fixed price delivery order is for the supply of Nurtec ODT 75 mg tablets. The contract has an ultimate completion date of May 6, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, covers the delivery of Nurtec ODT 75 mg tablets. The $3,041.34 firm fixed-price delivery order has a completion date of November 25, 2024. The contract is not designated as a set-aside award. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award, valued at $13,871.25, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Nurtec ODT 75 mg tablets, a pharmaceutical product used for medical treatment. The contract is a firm fixed-price Delivery Order with a period of performance through May 16, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Nurtec ODT 75 mg tablets. The contract has a ceiling value of $4,859.48 and a completion date of November 29, 2024. This award is a delivery order placed against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $33,761.90 firm-fixed-price delivery order is for the supply of Nurtec ODT 75 mg tablets. The contract has an ultimate completion date of September 6, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999, for delivering a comprehensive range of medical...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award has a ceiling value of $28,276.11 and is a delivery order contract with a firm fixed price pricing type. The contract delivers Nurtec ODT 75 MG Tablets and has an ultimate completion date of April 2, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $8,129.88, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, which is a delivery order, is for the supply of Nurtec ODT 75 mg tablets. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 30, 2025. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $3,918.18, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Nurtec ODT 75 mg tablets. The contract is a Firm Fixed Price Delivery Order with a performance period extending through May 8, 2025. The contract is not designated as a set-aside and was open to full and open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of the drug Nurtec ODT 75 mg Tablet in 8-count packages. The contract has a ceiling value of $35,079.25 and a completion date of September 24, 2024. It is a Firm Fixed Price Delivery Order contract, with no set-aside designation. Amerisourcebergen, as the prime contractor, will be responsible for supplying these...
  • SPE2DB22D2006
    Indefinite Delivery Contract
  • SPE2DB22D2006-SPE2DB25FV5VM
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Nurtec ODT 75 mg tablets. The firm-fixed-price delivery order has a ceiling value of $53,087.44 and a period of performance through October 24, 2024.

Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award is not designated as a set-aside and was competed openly. The contract supports essential medical commodities for federal agencies, including military treatment facilities, veterans' healthcare programs, and other government medical institutions.

Generated 1/22/25, 9:22 AM